Alignment Healthcare (NASDAQ:ALHC – Get Free Report) and INVO Fertility (NASDAQ:IVF – Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, analyst recommendations, profitability, institutional ownership, risk, dividends and earnings.
Profitability
This table compares Alignment Healthcare and INVO Fertility’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Alignment Healthcare | 0.89% | 20.02% | 3.46% |
| INVO Fertility | -116.29% | -85.54% | -31.05% |
Insider & Institutional Ownership
86.2% of Alignment Healthcare shares are held by institutional investors. Comparatively, 12.0% of INVO Fertility shares are held by institutional investors. 5.2% of Alignment Healthcare shares are held by insiders. Comparatively, 0.4% of INVO Fertility shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Analyst Ratings
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Alignment Healthcare | 0 | 4 | 7 | 0 | 2.64 |
| INVO Fertility | 1 | 0 | 0 | 1 | 2.50 |
Alignment Healthcare currently has a consensus price target of $23.60, suggesting a potential upside of 74.30%. INVO Fertility has a consensus price target of $20.00, suggesting a potential upside of 1,930.46%. Given INVO Fertility’s higher probable upside, analysts plainly believe INVO Fertility is more favorable than Alignment Healthcare.
Earnings & Valuation
This table compares Alignment Healthcare and INVO Fertility”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Alignment Healthcare | $3.95 billion | 0.71 | -$720,000.00 | $0.19 | 71.26 |
| INVO Fertility | $6.84 million | 0.36 | -$25.13 million | ($33.83) | -0.03 |
Alignment Healthcare has higher revenue and earnings than INVO Fertility. INVO Fertility is trading at a lower price-to-earnings ratio than Alignment Healthcare, indicating that it is currently the more affordable of the two stocks.
Risk and Volatility
Alignment Healthcare has a beta of 1.11, indicating that its share price is 11% more volatile than the S&P 500. Comparatively, INVO Fertility has a beta of 2.34, indicating that its share price is 134% more volatile than the S&P 500.
Summary
Alignment Healthcare beats INVO Fertility on 12 of the 15 factors compared between the two stocks.
About Alignment Healthcare
Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
About INVO Fertility
INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.
Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
